Using tiny biodegradable particles to disrupt the body’s normal immune response after a heart attack could help save patients from tissue damage and certain long-term health problems that often follow. Researchers have shown that injecting such particles into mice within 24 hours of a heart attack not only significantly reduces tissue damage, but also results in those mice having stronger cardiac function 30 days later. The inventors of the new technology now plan to pursue human trials.
Des chercheurs de l'Université de Colombie Britannique (UBC) ont développé un oxymètre de téléphone mobile qui pourrait sauver la vie de ceux qui vivent en dehors des secteurs couverts par les médecins.
De tous les problèmes auxquels les systèmes de santé dans le monde en développement doivent faire face, celle qui affecte le plus le Prof. Mark Ansermino est le fait que, comme il le dit, "les patients ne meurent pas à l'hôpital. Ils meurent à la maison".
It’s rare for me to hear a panel discussion on digital health and not hear the same conversation repeated and reiterated over and over again. In a discussion between health IT company CEOs at the JP Morgan Healthcare conference, some of the most interesting points raised were the ones the healthcare industry is struggling with the most. Of course, there were a lot of sound bites too. Here are five of the most interesting digital health insights.
The approaching March deadline for individuals to enroll in a health insurance plan is a useful reminder that provisions of Obamacare will continue to roll out this year. The Affordable Care Act and related legislation are putting a huge demand on the health system, from accelerating the shift to electronic medical records to creating a need for more efficient communication tools between physician offices, patients and insurers. A handful of industry insiders offers a glimpse of the kind of targets that will shift into focus in 2014 and the groups that will be looking to buy them.
Aux USA, malgré $800 milliards de dépenses l'an dernier dans la santé, 400.000 personnes sont mortes des conséquences d'erreurs médicales [1]. Une des raisons principales est que le domaine de la santé actuel ne bénéficie pas encore de toutes les avancées technologiques de notre époque : les appareils médicaux ne savent pas bien communiquer entre eux, l'information sur les traitements n'est pas correctement sauvegardée, standardisée, analysée, suivie et partagée. La technologie pourrait vraiment aider à éliminer nombre d'erreurs, comme elle l'a fait dans d'autres industries.
A nanoparticle wrapped in material taken from the membranes of red blood cells could become the basis for vaccines against a range of infectious bacteria, including MRSA (methicillin-resistant Staphylococcus aureus), an infection that kills tens of thousands of people every year.
Aethon, the premier developer of autonomous mobile robots for hospitals and health systems announced today that it received a $3.0 million investment from Mitsui & Co.
Some big data analytics companies strive to stand out with real-time mobile applications, captivating visualizations, or extra-simple search functions. And then there are startups targeting specific industries, like Zephyr Health, which takes in different kinds of data and displays findings in vertical-specific applications.
Zephyr’s approach just got some validation in the form of $15 million worth of venture funding. Kleiner Perkins Caufield & Byers and Jafco Ventures co-led the round. The new money will help Zephyr add to its engineering capabilities and build sales and marketing operations, Zephyr’s founder and chief executive, William King, told VentureBeat.
According to NEHI, prescription non-adherence is costing the US healthcare system $290B annually. Over 15% of the Medicare beneficiaries reach the prescription coverage gap or “Donut Hole” annually and over 50% of these beneficiaries discontinue medication refills. RxAdvance announced today a unique and patent-pending service called “Donut Hole Predictor & Medication Management Using Therapeutic Alternatives” solution that can predict which Medicare beneficiaries are likely to reach the donut hole very early into the benefit year, and how to prevent them from reaching it using innovative technology, people, and processes.
As a founder of the California Ear Institute at Stanford University, Rodney Perkins met many of the founding fathers of Silicon Valley. Among the surgeon’s friends—and sometime patients—were William Hewlett and David Packard; Intel’s (INTC) co-founder, Gordon Moore, and its former chief executive officer, Andy Grove; and Manhattan Project charter member Edward Teller, one of the inspirations for Dr. Strangelove.
